Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
CONCLUSIONS: Based on short-term (up to 12 months) follow-up, the effect of Aquablation on urological symptoms is probably similar to that of TURP (moderate-certainty evidence). The effect on quality of life may also be similar (low-certainty evidence). We are very uncertain whether patients undergoing Aquablation are at higher or lower risk for major adverse events (very low-certainty evidence). We are very uncertain whether Aquablation may result in little to no difference in erectile function but offer a small improvement in preservation of ejaculatory function (both very low-certainty evidence). These conclusions are based on a single study of men with a prostate volume up to 80 mL in size. Longer-term data and comparisons with other modalities appear critical to a more thorough assessment of the role of Aquablation for the treatment of LUTS in men with BPH.
PMID: 30759311 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Hwang EC, Jung JH, Borofsky M, Kim MH, Dahm P Tags: Cochrane Database Syst Rev Source Type: research
More News: Benign Prostatic Hyperplasia | Conferences | Databases & Libraries | General Medicine | Science | Study | Urology & Nephrology